Blood test may predict PRP success for arthritic knees

NCT ID NCT07617233

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looks at whether a routine blood test can predict which patients with knee osteoarthritis will get good pain relief from platelet-rich plasma (PRP) injections. Researchers will enroll 120 people aged 40-60 with moderate knee arthritis. Each person will receive three PRP injections and be followed for 6 months. The goal is to see if simple blood markers of inflammation can help doctors decide who is most likely to benefit from this treatment.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for KNEE OSTEOARTHRITIS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • University of Kyrenia, Dr. Suat Gunsel Hospital - Department of Orthopaedics and Traumatology

    Kyrenia, Cyprus

More trials for these conditions

Other studies related to the condition(s) this trial covers.